Aminofurazans as potent inhibitors of AKT kinase
Journal Article
·
· Bioorg. Med. Chem. Lett.
AKT inhibitors containing an imidazopyridine aminofurazan scaffold have been optimized. We have previously disclosed identification of the AKT inhibitor GSK690693, which has been evaluated in clinical trials in cancer patients. Herein we describe recent efforts focusing on investigating a distinct region of this scaffold that have afforded compounds (30 and 32) with comparable activity profiles to that of GSK690693.
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 1005680
- Journal Information:
- Bioorg. Med. Chem. Lett., Vol. 19, Issue (5) ; 03, 2009; ISSN 0960-894X
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase
Discovery of imidazo[1,2- a ]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model
Development of potent ALK inhibitor and its molecular inhibitory mechanism against NSCLC harboring EML4-ALK proteins
Journal Article
·
Wed Jul 22 00:00:00 EDT 2009
· J. Med. Chem.
·
OSTI ID:1005680
+25 more
Discovery of imidazo[1,2- a ]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model
Journal Article
·
Mon Feb 01 00:00:00 EST 2016
· Bioorganic and Medicinal Chemistry Letters
·
OSTI ID:1005680
+14 more
Development of potent ALK inhibitor and its molecular inhibitory mechanism against NSCLC harboring EML4-ALK proteins
Journal Article
·
Fri Aug 28 00:00:00 EDT 2015
· Biochemical and Biophysical Research Communications
·
OSTI ID:1005680
+11 more